Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ninan

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The Primary Care Companion for CNS Disorders|July 3, 2015
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive DisorderPhilip T Ninan, Jeff Musgnung, Michael Messig, et al.
Archives of General Psychiatry|August 1, 1984
A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implicationsT R Insel, P T Ninan, J Aloi, et al.
Psychopharmacology Bulletin|January 1, 1984
Behavioral and physiological responses to benzodiazepine receptor antagonistsJ N Crawley, P T Ninan, D Pickar, et al.
The Journal of Nervous and Mental Disease|March 30, 2013
Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT studyAlan J Gelenberg, David L Dunner, Anthony J Rothschild, et al.
The Primary Care Companion for CNS Disorders|November 12, 2016
Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-AnalysisThomas M Penders, Cornel N Stanciu, Alexander M Schoemann, et al.
CNS Spectrums|May 2, 2009
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorderMichael E Thase, Susan G Kornstein, Jean-Michel Germain, et al.
Archives of General Psychiatry|April 1, 1983
CSF prostaglandin levels in depressed and schizophrenic patientsM Linnoila, A R Whorton, D R Rubinow, et al.
Human Psychopharmacology|May 4, 2007
Tiagabine for social anxiety disorderBoadie W Dunlop, Laszlo Papp, Steven J Garlow, et al.
Science (New York, N.Y.)|December 24, 1982
Benzodiazepine receptor-mediated experimental "anxiety" in primatesP T Ninan, T M Insel, R M Cohen, et al.
The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The Primary Care Companion for CNS Disorders|July 3, 2015
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive DisorderPhilip T Ninan, Jeff Musgnung, Michael Messig, et al.
Archives of General Psychiatry|August 1, 1984
A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implicationsT R Insel, P T Ninan, J Aloi, et al.
Psychopharmacology Bulletin|January 1, 1984
Behavioral and physiological responses to benzodiazepine receptor antagonistsJ N Crawley, P T Ninan, D Pickar, et al.
The Journal of Nervous and Mental Disease|March 30, 2013
Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT studyAlan J Gelenberg, David L Dunner, Anthony J Rothschild, et al.
The Primary Care Companion for CNS Disorders|November 12, 2016
Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-AnalysisThomas M Penders, Cornel N Stanciu, Alexander M Schoemann, et al.
CNS Spectrums|May 2, 2009
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorderMichael E Thase, Susan G Kornstein, Jean-Michel Germain, et al.
Archives of General Psychiatry|April 1, 1983
CSF prostaglandin levels in depressed and schizophrenic patientsM Linnoila, A R Whorton, D R Rubinow, et al.
Human Psychopharmacology|May 4, 2007
Tiagabine for social anxiety disorderBoadie W Dunlop, Laszlo Papp, Steven J Garlow, et al.
Science (New York, N.Y.)|December 24, 1982
Benzodiazepine receptor-mediated experimental "anxiety" in primatesP T Ninan, T M Insel, R M Cohen, et al.
The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.
Pageof 12